ArticleCancers2023

Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy.

Mark Sutherland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.